ArticleOncology research2026

Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data.

Lorenzo Gasperoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.